Antiretrovirals for Prophylaxis Against COVID‐19: A Comprehensive Literature Review-Reference-Cited by-同舟云学术

Antiretrovirals for Prophylaxis Against COVID‐19: A Comprehensive Literature Review

Published:2020-12-06 Issue:5 Volume:61 Page:581-590
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Alavian Golbarg¹^ORCID,Kolahdouzan Kasra²^ORCID,Mortezazadeh Masoud³^ORCID,Torabi Zahra Sadat⁴^ORCID

Affiliation:

1. Department of Clinical Pharmacy Tehran University of Medical Sciences Tehran Iran

2. Radiation Oncology Department Radiation Oncology Research Center Imam Khomeini Hospital Complex Tehran University of Medical Sciences Tehran Iran

3. Internal Medicine Department Sina Hospital Tehran University of Medical Sciences Tehran Iran

4. Oral and Maxillofacial Surgery Department Shahid Beheshti University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1788

Reference69 articles.

1. World Health Organization. Weekly epidemiological update coronavirus disease 2019 (COVID‐19).https://www.who.int/publications/m/item/weekly-epidemiological-update---27-october-2020. Published October 27 2020. Accessed October 27 2020.

2. Risk of COVID‐19 among frontline healthcare workers and the general community: a prospective cohort study;Nguyen LH;medRxiv,2020

3. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

4. Clinical characteristics and outcomes in people living with HIV hospitalized for COVID‐19;Shalev N;Clin Infect Dis,2020

5. A survey for COVID‐19 among HIV/AIDS patients in two Districts of Wuhan, China;Guo W;AIDS Patients in Two Districts of Wuhan,2020

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with SARS-CoV-2 infection among people living with HIV: Data from the Balearic cohort (EVHIA);PLOS ONE;2024-08-07

2. Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections;Viruses;2024-04-22

3. Difference of Omicron variant infection and influence factors between people with and without HIV infection;2024-03-18

4. Antiretroviral therapy response: exploring the potential influence of SARS-CoV-2;Expert Review of Clinical Pharmacology;2024-02-28

5. Biomedical Risk Factors for COVID-19 among People Living with HIV during the First Wave of the Pandemic;Health Behavior and Policy Review;2023-12-01